U.S. Markets open in 3 hrs 34 mins

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.9100+0.0100 (+0.34%)
At close: 3:50PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.9000
Open2.9000
Bid2.9100 x 0
Ask2.9600 x 0
Day's Range2.8800 - 2.9600
52 Week Range1.8700 - 5.0000
Volume49,449
Avg. Volume90,319
Market Cap95.403M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.4980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.90
  • Hillebrand Acquires Braid
    CNW Group

    Hillebrand Acquires Braid

    MAINZ, Germany, Oct. 22, 2020 /CNW/ -- Hillebrand, a world leading forwarding, transport and logistics provider to the alcoholic beverage industry and products that require special care, officially announces its acquisition of Braid, a key player in bulk liquids logistics.

  • Cardiol Therapeutics' Cortalex(TM) CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
    Newsfile

    Cardiol Therapeutics' Cortalex(TM) CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

    The first pharmaceutically produced THC-free* extra-strength cannabidiol (CBD) Oakville, Ontario--(Newsfile Corp. - October 20, 2020) -  Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased to announce the commercial introduction of CortalexTM, a THC-free* extra-strength (100 mg/mL concentration) oral cannabidiol (CBD) formulation. CortalexTM is now available across Canada exclusively at Medical Cannabis by Shoppers™ online portal, a subsidiary ...

  • FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com
    Newsfile

    FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com

    Redondo Beach, California--(Newsfile Corp. - September 30, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering a potentially major development in the quest to improve outcomes for COVID-19 patients. The US Food and Drug Administration (FDA) recently approved an Investigational New Drug application by Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) that opens the door for Cardiol to ...